These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 30167802)

  • 1. Correction to: PET imaging of EGFR expression using an
    Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2245. PubMed ID: 30167802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of EGFR expression using an
    Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
    Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
    Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3.
    Notni J; Steiger K; Hoffmann F; Reich D; Schwaiger M; Kessler H; Wester HJ
    J Nucl Med; 2016 Oct; 57(10):1618-1624. PubMed ID: 27151985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virus.
    Li J; Gerlach RL; Jonsson CB; Gray BD; Pak KY; Ng CK
    Nucl Med Biol; 2015 Mar; 42(3):283-91. PubMed ID: 25537726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.
    Lütje S; Franssen GM; Sharkey RM; Laverman P; Rossi EA; Goldenberg DM; Oyen WJ; Boerman OC; McBride WJ
    Bioconjug Chem; 2014 Feb; 25(2):335-41. PubMed ID: 24382090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Publisher Correction: Spin-controlled atom-ion chemistry.
    Sikorsky T; Meir Z; Ben-Shlomi R; Akerman N; Ozeri R
    Nat Commun; 2018 Apr; 9(1):1669. PubMed ID: 29686374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
    Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
    Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.
    Aerts HJ; Dubois L; Perk L; Vermaelen P; van Dongen GA; Wouters BG; Lambin P
    J Nucl Med; 2009 Jan; 50(1):123-31. PubMed ID: 19091906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
    J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions.
    Harish A; Schwartz SA
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):273. PubMed ID: 32189231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
    J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and biological evaluation of
    Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT].
    Heusner TA; Fronz U; Jentzen W; Verhagen R; Forsting M; Bockisch A; Antoch G
    Rofo; 2007 Nov; 179(11):1159-65. PubMed ID: 17926254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex.
    Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K
    Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.